scispace - formally typeset
Search or ask a question

Showing papers by "Walter R. Gilks published in 1997"


BookDOI
TL;DR: The Markov Chain Monte Carlo Implementation Results Summary and Discussion MEDICAL MONITORING Introduction Modelling Medical Monitoring Computing Posterior Distributions Forecasting Model Criticism Illustrative Application Discussion MCMC for NONLINEAR HIERARCHICAL MODELS.
Abstract: INTRODUCING MARKOV CHAIN MONTE CARLO Introduction The Problem Markov Chain Monte Carlo Implementation Discussion HEPATITIS B: A CASE STUDY IN MCMC METHODS Introduction Hepatitis B Immunization Modelling Fitting a Model Using Gibbs Sampling Model Elaboration Conclusion MARKOV CHAIN CONCEPTS RELATED TO SAMPLING ALGORITHMS Markov Chains Rates of Convergence Estimation The Gibbs Sampler and Metropolis-Hastings Algorithm INTRODUCTION TO GENERAL STATE-SPACE MARKOV CHAIN THEORY Introduction Notation and Definitions Irreducibility, Recurrence, and Convergence Harris Recurrence Mixing Rates and Central Limit Theorems Regeneration Discussion FULL CONDITIONAL DISTRIBUTIONS Introduction Deriving Full Conditional Distributions Sampling from Full Conditional Distributions Discussion STRATEGIES FOR IMPROVING MCMC Introduction Reparameterization Random and Adaptive Direction Sampling Modifying the Stationary Distribution Methods Based on Continuous-Time Processes Discussion IMPLEMENTING MCMC Introduction Determining the Number of Iterations Software and Implementation Output Analysis Generic Metropolis Algorithms Discussion INFERENCE AND MONITORING CONVERGENCE Difficulties in Inference from Markov Chain Simulation The Risk of Undiagnosed Slow Convergence Multiple Sequences and Overdispersed Starting Points Monitoring Convergence Using Simulation Output Output Analysis for Inference Output Analysis for Improving Efficiency MODEL DETERMINATION USING SAMPLING-BASED METHODS Introduction Classical Approaches The Bayesian Perspective and the Bayes Factor Alternative Predictive Distributions How to Use Predictive Distributions Computational Issues An Example Discussion HYPOTHESIS TESTING AND MODEL SELECTION Introduction Uses of Bayes Factors Marginal Likelihood Estimation by Importance Sampling Marginal Likelihood Estimation Using Maximum Likelihood Application: How Many Components in a Mixture? Discussion Appendix: S-PLUS Code for the Laplace-Metropolis Estimator MODEL CHECKING AND MODEL IMPROVEMENT Introduction Model Checking Using Posterior Predictive Simulation Model Improvement via Expansion Example: Hierarchical Mixture Modelling of Reaction Times STOCHASTIC SEARCH VARIABLE SELECTION Introduction A Hierarchical Bayesian Model for Variable Selection Searching the Posterior by Gibbs Sampling Extensions Constructing Stock Portfolios With SSVS Discussion BAYESIAN MODEL COMPARISON VIA JUMP DIFFUSIONS Introduction Model Choice Jump-Diffusion Sampling Mixture Deconvolution Object Recognition Variable Selection Change-Point Identification Conclusions ESTIMATION AND OPTIMIZATION OF FUNCTIONS Non-Bayesian Applications of MCMC Monte Carlo Optimization Monte Carlo Likelihood Analysis Normalizing-Constant Families Missing Data Decision Theory Which Sampling Distribution? Importance Sampling Discussion STOCHASTIC EM: METHOD AND APPLICATION Introduction The EM Algorithm The Stochastic EM Algorithm Examples GENERALIZED LINEAR MIXED MODELS Introduction Generalized Linear Models (GLMs) Bayesian Estimation of GLMs Gibbs Sampling for GLMs Generalized Linear Mixed Models (GLMMs) Specification of Random-Effect Distributions Hyperpriors and the Estimation of Hyperparameters Some Examples Discussion HIERARCHICAL LONGITUDINAL MODELLING Introduction Clinical Background Model Detail and MCMC Implementation Results Summary and Discussion MEDICAL MONITORING Introduction Modelling Medical Monitoring Computing Posterior Distributions Forecasting Model Criticism Illustrative Application Discussion MCMC FOR NONLINEAR HIERARCHICAL MODELS Introduction Implementing MCMC Comparison of Strategies A Case Study from Pharmacokinetics-Pharmacodynamics Extensions and Discussion BAYESIAN MAPPING OF DISEASE Introduction Hypotheses and Notation Maximum Likelihood Estimation of Relative Risks Hierarchical Bayesian Model of Relative Risks Empirical Bayes Estimation of Relative Risks Fully Bayesian Estimation of Relative Risks Discussion MCMC IN IMAGE ANALYSIS Introduction The Relevance of MCMC to Image Analysis Image Models at Different Levels Methodological Innovations in MCMC Stimulated by Imaging Discussion MEASUREMENT ERROR Introduction Conditional-Independence Modelling Illustrative examples Discussion GIBBS SAMPLING METHODS IN GENETICS Introduction Standard Methods in Genetics Gibbs Sampling Approaches MCMC Maximum Likelihood Application to a Family Study of Breast Cancer Conclusions MIXTURES OF DISTRIBUTIONS: INFERENCE AND ESTIMATION Introduction The Missing Data Structure Gibbs Sampling Implementation Convergence of the Algorithm Testing for Mixtures Infinite Mixtures and Other Extensions AN ARCHAEOLOGICAL EXAMPLE: RADIOCARBON DATING Introduction Background to Radiocarbon Dating Archaeological Problems and Questions Illustrative Examples Discussion Index

7,399 citations


Journal ArticleDOI
TL;DR: In this paper, the authors consider scaling the proposal distribution of a multidimensional random walk Metropolis algorithm in order to maximize the efficiency of the algorithm and obtain a weak convergence result as the dimension of a sequence of target densities, n, converges to $\infty$.
Abstract: This paper considers the problem of scaling the proposal distribution of a multidimensional random walk Metropolis algorithm in order to maximize the efficiency of the algorithm. The main result is a weak convergence result as the dimension of a sequence of target densities, n, converges to $\infty$. When the proposal variance is appropriately scaled according to n, the sequence of stochastic processes formed by the first component of each Markov chain converges to the appropriate limiting Langevin diffusion process. The limiting diffusion approximation admits a straightforward efficiency maximization problem, and the resulting asymptotically optimal policy is related to the asymptotic acceptance rate of proposed moves for the algorithm. The asymptotically optimal acceptance rate is 0.234 under quite general conditions. The main result is proved in the case where the target density has a symmetric product form. Extensions of the result are discussed.

1,807 citations


Journal Article
TL;DR: In this paper, a hierarchical prior model is proposed to deal with weak prior information while avoiding the mathematical pitfalls of using improper priors in the mixture context, and a sample from the full joint distribution of all unknown variables is generated, which can be used as a basis for a thorough presentation of many aspects of the posterior distribution.
Abstract: New methodology for fully Bayesian mixture analysis is developed, making use of reversible jump Markov chain Monte Carlo methods that are capable of jumping between the parameter subspaces corresponding to different numbers of components in the mixture. A sample from the full joint distribution of all unknown variables is thereby generated, and this can be used as a basis for a thorough presentation of many aspects of the posterior distribution. The methodology is applied here to the analysis of univariate normal mixtures, using a hierarchical prior model that offers an approach to dealing with weak prior information while avoiding the mathematical pitfalls of using improper priors in the mixture context.

258 citations


Journal ArticleDOI
TL;DR: The proposed dynamic sampling algorithms use posterior samples from previous updating stages and exploit conditional independence between groups of parameters to allow samples of parameters no longer of interest to be discarded, such as when a patient dies or is discharged.
Abstract: In dynamic statistical modeling situations, observations arise sequentially, causing the model to expand by progressive incorporation of new data items and new unknown parameters. For example, in clinical monitoring, patients and data arrive sequentially, and new patient-specific parameters are introduced with each new patient. Markov chain Monte Carlo (MCMC) might be used for continuous updating of the evolving posterior distribution, but would need to be restarted from scratch at each expansion stage. Thus MCMC methods are often too slow for real-time inference in dynamic contexts. By combining MCMC with importance resampling, we show how real-time sequential updating of posterior distributions can be effected. The proposed dynamic sampling algorithms use posterior samples from previous updating stages and exploit conditional independence between groups of parameters to allow samples of parameters no longer of interest to be discarded, such as when a patient dies or is discharged. We apply the ...

251 citations


Journal ArticleDOI
TL;DR: Bayesian hierarchical-spatial models for disease mapping with imprecisely observed ecological covariates and smoothing priors are described and applied to an analysis of insulin Dependent Diabetes Mellitus incidence in Sardinia.
Abstract: We describe Bayesian hierarchical-spatial models for disease mapping with imprecisely observed ecological covariates. We posit smoothing priors for both the disease submodel and the covariate submodel. We apply the models to an analysis of insulin Dependent Diabetes Mellitus incidence in Sardinia, with malaria prevalence as a covariate.

103 citations


Journal ArticleDOI
TL;DR: The BSE maternal cohort study supports a role both for direct maternal transmission and for inherited genetic susceptibilty to the BSE agent, and actions to quantify, and minimize, the transmission risk from a mother with NVCJD to her baby, or to delivery teams, should be taken without delay.
Abstract: The bovine spongiform encephalopathy (BSE) maternal cohort study supports a role both for direct maternal transmission and for inherited genetic susceptibilty to the BSE agent. Additional data from the main BSE database do not resolve whether the risk of direct maternal transmission of BSE from dam to calf is concentrated in the interval within 5 months before the onset of BSE in the dam, as data from the BSE maternal cohort study suggest. The reason for this is that we cannot rely, as our analysis requires, on the survival of calves or traceability of the dam being independent of the interval from the birth of a calf to onset of BSE in the dam. Accordingly, for the present, we place most weight on evidence from the BSE maternal cohort study. Direct maternal transmission of the BSE agent from dam to calf has not been ruled out; vertical transmission of the new variant Creutzfeldt–Jakob disease (NVCJD) from mother with NVCJD to baby is therefore also possible. Actions to quantify, and minimize, the transmission risk, if any, from a mother with NVCJD to her baby, or to delivery teams, should be taken without delay.

31 citations